登陆/ 注册
×
Juno Therapeutics 电话:206-696-0703      邮箱:Info@junotherapeutics.com       官网: 成立时间:2013      地址:400 Dexter Avenue North Suite 1200 Seattle,WA 98109
公司简介
Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.
主要成员

Jose Baselga、Marc Lavigne、Howard Pien、Larry Corey、Richard Klausner

产品/服务
Chimeric Antigen Receptor (CAR) T cell Technologyhow CAR T cells bind the specificity of an antibody to the cytotoxic properties of killer T cells.
T Cell Receptor (TCR) Technologyhow our TCR constructs activate and co-stimulate T cells in a coordinated immune response against tumor cells.
融资信息
融资轮次融资日期投资方融资额度
Series A 2013-12ARCH Venture Partners、Alaska Permanent Fund1.2亿美元
Series A2014-04Bezos Expeditions、Venrock5.6千万美元
Series B2014-08Venrock、ARCH Venture Partners、Bezos Expeditions、Alaska Permanent Fund1.34亿美元
关联公司